Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer

Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer

Background: In 2007, Australia introduced a national human papillomavirus (HPV) vaccination program. In 2017, the onset of cervical screening changed from 18 to 25 years of age, utilising human papillomavirus (HPV) nucleic acid testing. The objective of the study is to describe the HPV genotypes and...

Full description

Bibliographic Details
Main Authors: Yasmin L. Jayasinghe, Sepehr N. Tabrizi, Matthew Stevens, Trishe Y-M. Leong, Jan Pyman, Sonia R. Grover, Suzanne M. Garland, the Early-Onset Cervical Cancer (EOCC) Study Group
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Pathogens
Subjects:
cervical cancer
young women
human papillomavirus
genotyping
HPV vaccine
HPV16 variants
Online Access:https://www.mdpi.com/2076-0817/12/3/451

Similar Items

Similar Items